Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DCL000753

Drug Information
SynonymsCID132412; CHEMBL90544; CHEMBL92357; AC1L30XJ; 142155-43-9; Cizolirtine [INN]; MolPort-005-942-571; Cizolirtine; AC1MI3GX; UNII-SMP167WV5D; CID3037765; N,N-dimethyl-2-[(R)-(2-methylpyrazol-3-yl)-phenylmethoxy]ethanamine; CHEMBL92501; N,N-dimethyl-2-[(2-methylpyrazol-3-yl)-phenylmethoxy]ethanamine; CID10220803
CompanyEsteve Laboratories
IndicationNeuropathic pain
[ICD9: 338,780   ICD10: R52, G89]
Phase II    [1]

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Canonical SMILESCN1C(=CC=N1)C(C2=CC=CC=C2)OCCN(C)C    
Therapeutic ClassAnalgesics
CAS NumberCAS 142155-44-0
PubChem Compound IDCID 132412.
PubChem Substance IDSID 11542386.
TargetCalcitonin gene-related peptideInhibitor[1]
Ref 1Emerging drugs in neuropathic pain. Expert Opin Emerg Drugs. 2007 Mar;12(1):113-26. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links


Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543